デフォルト表紙
市場調査レポート
商品コード
1376009

細胞増殖の市場規模、シェア、動向分析レポート:製品別、セルタイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年~2030年

Cell Expansion Market Size, Share & Trends Analysis Report By Product (Instruments, Culture Flasks & Accessories, Consumables), By Cell Type (Mammalian, Microbial), By Application, By End-use, By Region, And Segment Forecasts, 2023 - 2030

出版日: | 発行: Grand View Research | ページ情報: 英文 170 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
細胞増殖の市場規模、シェア、動向分析レポート:製品別、セルタイプ別、用途別、最終用途別、地域別、セグメント別予測、2023年~2030年
出版日: 2023年10月25日
発行: Grand View Research
ページ情報: 英文 170 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

細胞増殖市場の成長と動向:

Grand View Research, Inc.の最新レポートによると、世界の細胞増殖市場規模は2030年までに471億3,000万米ドルに達し、CAGRは12.85%に達すると予測されています。

細胞拡大技術は、1回の臍帯血採取から細胞療法や遺伝子療法を開発するために採用されることが多くなっています。これらの技術は、がん治療開発のための保存幹細胞(SC)の拡大にも使用できます。したがって、臍帯血SCs拡大技術の著しい開拓が市場成長を押し上げると予想されます。

企業は、組織工学製品の拡大や生物製剤の開発のために多額の投資を行っています。例えば、2019年3月、Merck KGaAはスイスの生物製剤製造施設の拡張のために1億6,800万米ドルを投資しました。このような取り組みにより、生物製剤開発に必要なソリューションの需要が高まり、市場の成長につながると期待されています。

バイオリアクターはこの市場における基本的なツールです。バイオリアクター工学的アプローチの応用に関する広範な調査研究が、新規培養技術の導入につながっています。さらに、自動バイオリアクターとマイクロキャリア技術の併用は、がんSCの効率的な増殖と濃縮につながります。その結果、これらのアプローチはこの市場で絶大な支持を得ています。

細胞増殖市場のレポートハイライト

  • 自動細胞増殖システムの幅広いポートフォリオと、大規模な生物生産のためのバイオリアクター設計の改善により、機器に有利な成長機会がもたらされます。
  • 微生物細胞分野は、ハイスループット培養アプローチとバイオフィルムの形成を回避する技術の導入により、最も速い成長率が見込まれます。
  • バイオ医薬品分野は、バイオシミラーの需要の伸び、バイオ製造への継続的な研究開発投資、生物製剤の承認件数の増加により、2022年に最大の収益シェアを占めました。
  • 2023年から2030年にかけては、生物医学産業の発展分野に焦点を当てる複数のコンソーシアムの存在により、アジア太平洋地域が最も速いCAGRを記録すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 細胞増殖市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • 細胞増殖市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 細胞増殖市場:製品の推定・動向分析

  • 細胞増殖市場:重要なポイント
  • 細胞増殖市場:製品動向と市場シェア分析、2022年および2030年
  • 消耗品
  • 培養用フラスコとアクセサリー
  • 機器

第5章 細胞増殖市場:セルタイプの推定・動向分析

  • 細胞増殖市場:重要なポイント
  • 細胞増殖市場:セルタイプの動向と市場シェア分析、2022年および2030年
  • 哺乳類細胞
  • 微生物細胞
  • その他

第6章 細胞増殖市場:用途の推定・動向分析

  • 細胞増殖市場:重要なポイント
  • 細胞増殖市場:用途の動向と市場シェア分析、2022年および2030年
  • バイオ医薬品
  • 組織培養と工学
  • ワクチンの製造
  • 創薬
  • 遺伝子治療
  • がん調査
  • 幹細胞の調査
  • その他の用途

第7章 細胞増殖市場:最終用途の推定・動向分析

  • 細胞増殖市場:重要なポイント
  • 細胞増殖市場:最終用途の動向と市場シェア分析、2022年および2030年
  • バイオテクノロジーおよびバイオ医薬品企業
  • 研究機関
  • 細胞バンク
  • その他

第8章 細胞増殖市場:地域の推定・動向分析

  • 地域別の展望
  • 地域別の細胞増殖市場:マーケットプレースでの重要なポイント
  • 北米
    • 市場推計・予測、2018~2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第9章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 会社/競合の分類
    • Thermo Fisher Scientific, Inc.
    • GE Healthcare
    • Corning Incorporated
    • Merck KGaA
    • Miltenyi Biotec
    • BD (Becton, Dickinson and Company)
    • TERUMO BCT, INC.
    • Sartorius AG
    • Takara Bio Inc.
    • TRINOVA BIOCHEM GmbH
    • upcyte technologies GmbH
図表

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 3 North America cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 5 North America cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America cell expansion market, by region, 2018 - 2030 (USD Million)
  • Table 7 U.S. cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 8 U.S. cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.S. cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 10 U.S. cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Canada cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 12 Canada cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 13 Canada cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 14 Canada cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 16 Europe cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 17 Europe cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 18 Europe cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe cell expansion market, by region, 2018 - 2030 (USD Million)
  • Table 20 Germany cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 21 Germany cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 22 Germany cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 23 Germany cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 24 UK cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 25 UK cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 26 UK cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 27 UK cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 28 France cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 29 France cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 30 France cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 31 France cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 32 Italy cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 33 Italy cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 34 Italy cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 35 Italy cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Spain cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 37 Spain cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 38 Spain cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 39 Spain cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Denmark cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 41 Denmark cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 42 Denmark cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 43 Denmark cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Sweden cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 45 Sweden cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 46 Sweden cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 47 Sweden cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Norway cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 49 Norway cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 50 Norway cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 51 Norway cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 52 Asia Pacific cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 53 Asia Pacific cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 54 Asia Pacific cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 55 Asia Pacific cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Asia Pacific cell expansion market, by region, 2018 - 2030 (USD Million)
  • Table 57 Japan cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 58 Japan cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 59 Japan cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 60 Japan cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 61 China cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 62 China cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 63 China cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 64 China cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 65 India cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 66 India cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 67 India cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 68 India cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Australia cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 70 Australia cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 71 Australia cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 72 Australia cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Thailand cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 74 Thailand cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 75 Thailand cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 76 Thailand cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 77 South Korea cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 78 South Korea cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 79 South Korea cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 80 South Korea cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 81 Latin America cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 82 Latin America cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 83 Latin America cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 84 Latin America cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 85 Latin America cell expansion market, by region, 2018 - 2030 (USD Million)
  • Table 86 Brazil cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 87 Brazil cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 88 Brazil cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 89 Brazil cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 90 Mexico cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 91 Mexico cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 92 Mexico cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 93 Mexico cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 94 Argentina cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 95 Argentina cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 96 Argentina cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 97 Argentina cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 98 Middle East and Africa cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 99 Middle East and Africa cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 100 Middle East and Africa cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 101 Middle East and Africa cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 102 Middle East and Africa cell expansion market, by region, 2018 - 2030 (USD Million)
  • Table 103 South Africa cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 104 South Africa cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 105 South Africa cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 106 South Africa cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 107 Saudi Arabia cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 108 Saudi Arabia cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 109 Saudi Arabia cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 110 Saudi Arabia cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 111 UAE cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 112 UAE cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 113 UAE cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 114 UAE cell expansion market, by end use, 2018 - 2030 (USD Million)
  • Table 115 Kuwait cell expansion market, by cell type, 2018 - 2030 (USD Million)
  • Table 116 Kuwait cell expansion market, by product, 2018 - 2030 (USD Million)
  • Table 117 Kuwait cell expansion market, by application, 2018 - 2030 (USD Million)
  • Table 118 Kuwait cell expansion market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Cell expansion: Market outlook
  • Fig. 8 Cell expansion: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Cell expansion market driver impact
  • Fig. 13 Cell expansion market restraint impact
  • Fig. 14 Cell expansion market strategic initiatives analysis
  • Fig. 15 Cell expansion market: Product movement analysis
  • Fig. 16 Cell expansion market: Product outlook and key takeaways
  • Fig. 17 Consumables market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Culture flasks and accessories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Instruments market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Cell expansion market: Cell type movement analysis
  • Fig. 21 Cell expansion market: Cell type outlook and key takeaways
  • Fig. 22 Mammalian market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Microbial market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Cell expansion market: Application movement analysis
  • Fig. 26 Cell expansion market: Application outlook and key takeaways
  • Fig. 27 Biopharmaceuticals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Tissue culture & engineering market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Vaccine production market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Drug development market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Gene therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Cancer research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Stem cell research market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Cell expansion market: End use movement analysis
  • Fig. 36 Cell expansion market: End use outlook and key takeaways
  • Fig. 37 Biopharmaceuticals & biotechnology companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Research institutes market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Cell banks market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Other market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Global cell expansion market: Regional movement analysis
  • Fig. 42 Global cell expansion market: Regional outlook and key takeaways
  • Fig. 43 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)
目次
Product Code: GVR-4-68038-665-3

Cell Expansion Market Growth & Trends:

The global cell expansion market size is expected to reach USD 47.13 billion by 2030 registering a CAGR of 12.85%, according to a new report by Grand View Research, Inc.. Cell expansion techniques are increasingly employed for the development of cellular and gene therapies from a single cord blood collection. These techniques can also be used for the expansion of stored Stem Cells (SCs) for the development of cancer therapies. Therefore, significant developments in cord blood SCs expansion technologies are expected to boost market growth.

Companies have made heavy investments for the expansion of tissue-engineered products and the development of biologics. For instance, in March 2019, Merck KGaA invested USD 168 million for the expansion of its biologics manufacturing facility in Switzerland. Such initiatives are expected to boost the demand for solutions required for biologic development, thereby leading to market growth.

Bioreactors are fundamental tools in this market. Extensive research studies related to the applications of bioreactor engineering approaches have led to the incorporation of novel culture technologies. Moreover, the combined use of automated bioreactors with the microcarrier technology leads to an efficient expansion and enrichment of the cancer SCs. As a result, these approaches have gained immense traction in this market.

Cell Expansion Market Report Highlights:

  • Broad portfolio of automated expansion systems along with improvements in bioreactor design for large-scale bioproduction results in the lucrative growth opportunity for instruments
  • The microbial cells segment is expected to witness the fastest growth rate owing to the implementation of high-throughput cultivation approaches and techniques that avoid the formation of biofilms
  • Biopharmaceuticals segment held the largest revenue share in 2022 due to growth in the demand for biosimilars, continuous R&D investments in biomanufacturing, and rise in the number of approvals for biologics
  • Asia Pacific is expected to witness the fastest CAGR from 2023 to 2030 due to presence of several consortiums that focus on the evolving fields in the biomedical industry

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Cell type
    • 1.1.3. Application
    • 1.1.4. End use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product
    • 2.2.2. Cell Type outlook
    • 2.2.3. Application outlook
    • 2.2.4. End use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cell Expansion Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Cell Expansion Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's Five Forces
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Cell Expansion Market: Product Estimates & Trend Analysis

  • 4.1. Cell Expansion Market: Key Takeaways
  • 4.2. Cell Expansion Market: Product Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Consumables
    • 4.3.1. Consumables market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.2. Reagents, media & serum
      • 4.3.2.1. Reagents, media & serum market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.3.3. Other consumables
      • 4.3.3.1. Other consumables market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Cultural flasks and accessories
    • 4.4.1. Cultural flasks and accessories market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.2. Tissue culture flasks
      • 4.4.2.1. Tissue culture flasks market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.3. Bioreactor accessories
      • 4.4.3.1. Bioreactor accessories market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.4.4. Other culture flasks and accessories
      • 4.4.4.1. Other culture flasks and accessories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Instruments
    • 4.5.1. Instruments market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.2. Automated cell expansion systems
      • 4.5.2.1. Automated cell expansion systems market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.3. Cell counters
      • 4.5.3.1. Cell counters market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.4. Centrifuges
      • 4.5.4.1. Centrifuges market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.5. Bioreactors
      • 4.5.5.1. Bioreactors market estimates and forecasts, 2018 to 2030 (USD Million)
    • 4.5.6. Other instruments
      • 4.5.6.1. Other instruments market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cell Expansion Market: Cell Type Estimates & Trend Analysis

  • 5.1. Cell Expansion Market: Key Takeaways
  • 5.2. Cell Expansion Market: Cell Type Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Mammalian cells
    • 5.3.1. Mammalian cells market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.2. Human cells
      • 5.3.2.1. Human cells market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.2.2. Stem cells
      • 5.3.2.2.1. Stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.2.2.2. Adult stem cells
      • 5.3.2.2.2.1. Adult cells market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.2.2.3. Induced pluripotent stem cells
      • 5.3.2.2.3.1. Induced pluripotent stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.2.2.4. Embryonic stem cells
      • 5.3.2.2.4.1. Embryonic stem cells market estimates and forecasts, 2018 to 2030 (USD Million)
      • 5.3.2.3. Differentiated cells
      • 5.3.2.3.1. Differentiated cells market estimates and forecasts, 2018 to 2030 (USD Million)
    • 5.3.3. Animal cells
      • 5.3.3.1. Animal cells market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Microbial cells
    • 5.4.1. Microbial cells market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Other cell types market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cell Expansion Market: Application Estimates & Trend Analysis

  • 6.1. Cell Expansion Market: Key Takeaways
  • 6.2. Cell Expansion Market: Application Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Biopharmaceuticals
    • 6.3.1. Biopharmaceuticals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Tissue culture & engineering
    • 6.4.1. Tissue culture & engineering market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Vaccine production
    • 6.5.1. Vaccine production market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Drug development
    • 6.6.1. Drug development market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Gene therapy
    • 6.7.1. Gene therapy market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.8. Cancer research
    • 6.8.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.9. Stem cell research
    • 6.9.1. Stem cell research market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.10. Other applications
    • 6.10.1. Other applications market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cell Expansion Market: End Use Estimates & Trend Analysis

  • 7.1. Cell Expansion Market: Key Takeaways
  • 7.2. Cell Expansion Market: End-use Movement & Market Share Analysis, 2022 & 2030
  • 7.3. Biotechnology & biopharmaceutical companies
    • 7.3.1. Biotechnology & biopharmaceutical companies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.4. Research institutes
    • 7.4.1. Research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.5. Cell banks
    • 7.5.1. Cell banks market estimates and forecasts, 2018 to 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 8. Cell Expansion Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Outlook
  • 8.2. Cell Expansion Market by Region: Key Marketplace Takeaways
  • 8.3. North America
    • 8.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.4. Europe
    • 8.4.1. UK
      • 8.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.2. Germany
      • 8.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.3. France
      • 8.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.4. Italy
      • 8.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.5. Spain
      • 8.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.6. Denmark
      • 8.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.4.8. Norway
      • 8.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Japan
      • 8.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.2. China
      • 8.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.3. India
      • 8.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.4. Australia
      • 8.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.5. Thailand
      • 8.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.5.6. South Korea
      • 8.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.6. Latin America
    • 8.6.1. Brazil
      • 8.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.2. Mexico
      • 8.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 8.7. MEA
    • 8.7.1. South Africa
      • 8.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.2. Saudi Arabia
      • 8.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.3. UAE
      • 8.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 8.7.4. Kuwait
      • 8.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 9.2. Company/Competition Categorization
    • 9.2.1. Thermo Fisher Scientific, Inc.
      • 9.2.1.1. Company overview
      • 9.2.1.2. Financial performance
      • 9.2.1.3. Product benchmarking
      • 9.2.1.4. Strategic initiatives
    • 9.2.2. GE Healthcare
      • 9.2.2.1. Company overview
      • 9.2.2.2. Financial performance
      • 9.2.2.3. Product benchmarking
      • 9.2.2.4. Strategic initiatives
    • 9.2.3. Corning Incorporated
      • 9.2.3.1. Company overview
      • 9.2.3.2. Financial performance
      • 9.2.3.3. Product benchmarking
      • 9.2.3.4. Strategic initiatives
    • 9.2.4. Merck KGaA
      • 9.2.4.1. Company overview
      • 9.2.4.2. Financial performance
      • 9.2.4.3. Product benchmarking
      • 9.2.4.4. Strategic initiatives
    • 9.2.5. Miltenyi Biotec
      • 9.2.5.1. Company overview
      • 9.2.5.2. Financial performance
      • 9.2.5.3. Product benchmarking
      • 9.2.5.4. Strategic initiatives
    • 9.2.6. BD (Becton, Dickinson and Company)
      • 9.2.6.1. Company overview
      • 9.2.6.2. Financial performance
      • 9.2.6.3. Product benchmarking
      • 9.2.6.4. Strategic initiatives
    • 9.2.7. TERUMO BCT, INC.
      • 9.2.7.1. Company overview
      • 9.2.7.2. Financial performance
      • 9.2.7.3. Product benchmarking
      • 9.2.7.4. Strategic initiatives
    • 9.2.8. Sartorius AG
      • 9.2.8.1. Company overview
      • 9.2.8.2. Financial performance
      • 9.2.8.3. Product benchmarking
      • 9.2.8.4. Strategic initiatives
    • 9.2.9. Takara Bio Inc.
      • 9.2.9.1. Company overview
      • 9.2.9.2. Financial performance
      • 9.2.9.3. Product benchmarking
      • 9.2.9.4. Strategic initiatives
    • 9.2.10. TRINOVA BIOCHEM GmbH
      • 9.2.10.1. Company overview
      • 9.2.10.2. Financial performance
      • 9.2.10.3. Product benchmarking
      • 9.2.10.4. Strategic initiatives
    • 9.2.11. upcyte technologies GmbH
      • 9.2.11.1. Company overview
      • 9.2.11.2. Financial performance
      • 9.2.11.3. Product benchmarking
      • 9.2.11.4. Strategic initiatives